SCHEMBL29527481

SCHEMBL29527481

CCCCOC(=O)Nc1cc(Br)cnc1OC

nearest known ligand 0.51

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 3/20 0.51
ALDH1A1 P00352 2/20 0.51
TSHR P16473 2/20 0.51
LMNA P02545 2/20 0.51
NPSR1 Q6W5P4 1/20 0.51
HPGD P15428 3/20 0.47
KDM4E B2RXH2 1/20 0.47
CYP1A2 P05177 2/20 0.47
CYP2C19 P33261 2/20 0.47
SMN1; SMN2 Q16637 2/20 0.47
CNR2 P34972 1/20 0.45
RAB9A P51151 3/20 0.43
NPC1 O15118 2/20 0.43
CASP1 P29466 1/20 0.43
EGFR P00533 6/20 0.42
KDR P35968 6/20 0.42
CYP2C9 P11712 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2067101 0.77 PIK3CD (0.42) ALDH1A1TSHRCYP1A2SMN1; SMN2
SCHEMBL29527107 0.76 AAK1 (0.49) ALDH1A1CYP1A2CYP2C19SMN1; SMN2RAB9A
SCHEMBL21500091 0.76 AAK1 (0.49) ALDH1A1CYP1A2CYP2C19SMN1; SMN2RAB9A
SCHEMBL187591 0.72 CNR2 (0.42) LMNACYP1A2CYP2C19SMN1; SMN2CNR2
SCHEMBL1771736 0.72 MEN1 (0.38) LMNAKDM4ESMN1; SMN2RAB9ANPC1
SCHEMBL11659268 0.72 ALDH1A1 (0.80) L3MBTL1ALDH1A1TSHRLMNANPSR1
SCHEMBL31287064 0.72 ALDH1A1 (0.54) ALDH1A1TSHRNPSR1HPGDKDM4E
SCHEMBL16696397 0.71 SMN1; SMN2 (0.56) L3MBTL1ALDH1A1TSHRLMNANPSR1
SCHEMBL31078996 0.71 SMN1; SMN2 (0.56) L3MBTL1ALDH1A1TSHRLMNANPSR1
SCHEMBL7407182 0.70 SMN1; SMN2 (0.53) L3MBTL1ALDH1A1TSHRLMNANPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4240730-A1 2-PYRIDONES AS THYROID HORMONE RECEPTOR MODULATORS Aligos Therapeutics, Inc. (US) 2023-09-13 EP disclosed
WO-2022099044-A1 2-PYRIDONES AS THYROID HORMONE RECEPTOR MODULATORS ALIGOS THERAPEUTICS, INC. (US) 2022-05-12 WO disclosed